Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement the Randomized BRAVO-3 Trial

Journal of the American College of Cardiology

Volumn 66, Issue 25, 2015, Pages 2860-2868

  Dangas, George D ^a   Lefèvre, Thierry ^b   Kupatt, Christian ^c   Tchetche, Didier ^d   Schäfer, Ulrich ^e,z   Dumonteil, Nicolas ^f   Webb, John G ^g   Colombo, Antonio ^h   Windecker, Stephan ⁱ   Ten Berg, Jurriën M ^j   Hildick Smith, David ^k   Mehran, Roxana ^a   Boekstegers, Peter ^l   Linke, Axel ^m   Tron, Christophe ⁿ   Van Belle, Eric ^o   Asgar, Anita W ^p   Fach, Andreas ^q   Jeger, Raban ^r   Sardella, Gennaro ^s   Hink, Hans Ulrich ^t   Husser, Oliver ^u   Grube, Eberhard ^v   Deliargyris, Efthymios N ^w   Lechthaler, Ilknur ^x   Bernstein, Debra ^w   Wijngaard, Peter ^x   Anthopoulos, Prodromos ^x   Hengstenberg, Christian ^u,y   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Hospital Privé Jacques Cartier   (France)

^c UNIVERSITY OF MUNICH   (Germany)

^d CLINIQUE PASTEUR   (France)

^e UNIVERSITY HEART CENTER HAMBURG   (Germany)

^f CHU RANGUEIL   (France)

^g ST PAUL S HOSPITAL   (Canada)

^h SAN RAFFAELE HOSPITAL   (Italy)

ⁱ UNIVERSITY OF BERN   (Switzerland)

^j ST ANTONIUS HOSPITAL   (Netherlands)

^k Worthing Hospital   (United Kingdom)

^l Heart Center Siegburg   (Germany)

^m UNIVERSITY OF LEIPZIG   (Germany)

ⁿ ROUEN UNIVERSITY HOSPITAL   (France)

^o LILLE UNIVERSITY HOSPITAL   (France)

^p MONTREAL HEART INSTITUTE   (Canada)

^q Klinikum Links der Weser   (Germany)

^r UNIVERSITY HOSPITAL BASEL   (Switzerland)

^s POLICLINICO UMBERTO I   (Italy)

^t UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^u TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^v UNIVERSITY HOSPITAL BONN   (Germany)

^w MEDICINES COMPANY   (United States)

^x Medicines Company   (Switzerland)

^y DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^z DEPARTMENT OF CARDIOLOGY   (Germany)

more..

Author keywords

anticoagulation; bivalirudin; major bleeding; transcatheter aortic valve replacement

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; HIRULOG; ANTICOAGULANT AGENT; ANTITHROMBIN; HIRUDIN DERIVATIVE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ACUTE KIDNEY FAILURE; AGED; ANTICOAGULATION; AORTA VALVE STENOSIS; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; AORTIC VALVE STENOSIS; CHEMICALLY INDUCED; CLINICAL TRIAL; DOSE RESPONSE; ECHOCARDIOGRAPHY; EUROPE; FOLLOW UP; INCIDENCE; MULTICENTER STUDY; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDY; SURVIVAL RATE; THROMBOEMBOLISM; TREATMENT OUTCOME; TRENDS; UNITED STATES; VERY ELDERLY;

AGED, 80 AND OVER; ANTICOAGULANTS; ANTITHROMBINS; AORTIC VALVE STENOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; EUROPE; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HIRUDINS; HUMANS; INCIDENCE; MALE; PEPTIDE FRAGMENTS; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOEMBOLISM; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME; UNITED STATES;

EID: 84955467231     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.10.003     Document Type: Article

References (22)

1. V.T. Nkomo, J.M. Gardin, T.N. Skelton, J.S. Gottdiener, C.G. Scott, and M. Enriquez-Sarano Burden of valvular heart diseases: a population-based study Lancet 368 2006 1005 1011
2. R.A. Nishimura, C.M. Otto, R.O. Bonow, and et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 2014 e57 e185
3. S.K. Kodali, M.R. Williams, C.R. Smith, and et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement N Engl J Med 366 2012 1686 1695
4. M.B. Leon, C.R. Smith, M. Mack, and et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
5. R.R. Makkar, G.P. Fontana, H. Jilaihawi, and et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis N Engl J Med 366 2012 1696 1704
6. C.R. Smith, M.B. Leon, M.J. Mack, and et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
7. G.W. Stone, B.T. McLaurin, D.A. Cox, and et al. Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216
8. Y. Han, J. Guo, Y. Zheng, and et al. Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial JAMA 313 2015 1336 1346
9. G.W. Stone, B. Witzenbichler, G. Guagliumi, and et al. Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
10. P.G. Steg, A. van't Hof, C.W. Hamm, and et al. Bivalirudin started during emergency transport for primary PCI N Engl J Med 369 2013 2207 2217
11. G.W. Stone, H.D. White, E.M. Ohman, and et al. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial Lancet 369 2007 907 919
12. M. Valgimigli, E. Frigoli, S. Leonardi, and et al. Bivalirudin or unfractionated heparin in acute coronary syndromes N Engl J Med 373 2015 997 1009
13. A. Kini, J. Yu, M.G. Cohen, and et al. Effect of bivalirudin on aortic valve intervention outcomes study: a two-centre registry study comparing bivalirudin and unfractionated heparin in balloon aortic valvuloplasty EuroIntervention 10 2014 312 319
14. P. Lange, M. Greif, D. Bongiovanni, and et al. Bivalirudin vs heparin in patients who undergo transcatheter aortic valve implantation Can J Cardiol 31 2015 998 1003
15. Z. Sergie, T. Lefevre, E. Van Belle, and et al. Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies J Thromb Thrombolysis 35 2013 483 493
16. R. Mehran, S.V. Rao, D.L. Bhatt, and et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
17. G.W. Stone, R. Mehran, P. Goldstein, and et al. Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials J Am Coll Cardiol 65 2015 27 38
18. G.W. Stone, B. Witzenbichler, G. Guagliumi, and et al. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial Lancet 377 2011 2193 2204
19. S. Marechaux, D. Corseaux, A. Vincentelli, and et al. Identification of tissue factor in experimental aortic valve sclerosis Cardiovasc Pathol 18 2009 67 76
20. J. Breyne, F. Juthier, D. Corseaux, and et al. Atherosclerotic-like process in aortic stenosis: activation of the tissue factor-thrombin pathway and potential role through osteopontin alteration Atherosclerosis 213 2010 369 376
21. R.R. Makkar, G. Fontana, H. Jilaihawi, and et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves N Engl J Med 373 2015 2015 2024
22. D.H. Adams, J.J. Popma, M.J. Reardon, and et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis N Engl J Med 370 2014 1790 1798